In contrast, TRAIL (tumour necrosis factor-related apoptosis inducing ligand) was reported to be highly effective in targeting and destroying a variety of tumors, including colorectal cancer [12], glioblastoma [13], and NSCLC [14], without any toxicities. This evidence concerns the gene TNFSF10 and non-small cell lung carcinoma.